Study on Subcutaneous Blinatumomab for Children with Difficult or Returning B-Cell Precursor Acute Lymphoblastic Leukemia | Clinical Trial

Study on Subcutaneous Blinatumomab for Children with Difficult or Returning B-Cell Precursor Acute Lymphoblastic Leukemia | Clinical Trial | Right2Hope